Just like a mystery novel with new clues being uncovered every day, scientists are continuously acquiring fresh data and discovering innovative insights about Alzheimer’s disease (AD). Initially identified in the early 1900s, key players such as amyloid-beta (Aβ), tau, vascular abnormalities, gliosis, and potential infections have shaped our understanding of this debilitating form of dementia. Recently, there has been increasing recognition of neurovascular unit dysfunction as a precursor to mild cognitive impairment (MCI), occurring independently of Aβ and tau accumulation. Intriguingly, it has been proposed that Aβ and tau oligomers may actually be antimicrobial peptides generated in response to infections, challenging long-held beliefs about their origins. This leads us to the captivating notion that pathogenic germs could trigger an innate immune response in peripheral organs, leading to incidents of dementia. However, this hypothesis requires further investigation. Meanwhile, our complex biology plays a role in defining our susceptibility to Alzheimer’s, including individual risk factors influencing immune status, neurovascular function, and neuronal plasticity. To delve deeper into the connection between infections, organ dysfunction, and Alzheimer’s disease, this focused review explores the generation of peripheral amyloids and neurovascular unit dysfunction. While many questions remain unanswered, this article highlights critical avenues for future research.
Alzheimer’s disease (AD) is the most common form of dementia. It was first described more than a century ago, and scientists are acquiring new data and learning novel information about the disease every day. Although there are nuances and details continuously being unraveled, many key players were identified in the early 1900’s by Dr. Oskar Fischer and Dr. Alois Alzheimer, including amyloid-beta (Aβ), tau, vascular abnormalities, gliosis, and a possible role of infections. More recently, there has been growing interest in and appreciation for neurovascular unit dysfunction that occurs early in mild cognitive impairment (MCI) before and independent of Aβ and tau brain accumulation. In the last decade, evidence that Aβ and tau oligomers are antimicrobial peptides generated in response to infection has expanded our knowledge and challenged preconceived notions. The concept that pathogenic germs cause infections generating an innate immune response (e.g., Aβ and tau produced by peripheral organs) that is associated with incident dementia is worthwhile considering in the context of sporadic AD with an unknown root cause. Therefore, the peripheral amyloid hypothesis to cognitive impairment and AD is proposed and remains to be vetted by future research. Meanwhile, humans remain complex variable organisms with individual risk factors that define their immune status, neurovascular function, and neuronal plasticity. In this focused review, the idea that infections and organ dysfunction contribute to Alzheimer’s disease, through the generation of peripheral amyloids and/or neurovascular unit dysfunction will be explored and discussed. Ultimately, many questions remain to be answered and critical areas of future exploration are highlighted.
Dr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for the Success of Society. With a keen interest in exploring the untapped potential of the human mind, Dr. Lowemann has dedicated his career to pushing the boundaries of human capabilities and understanding.
Armed with a Master of Science degree and a Ph.D. in his field, Dr. Lowemann has consistently been at the forefront of research and innovation, delving into ways to optimize human performance, cognition, and overall well-being. His work at the Institute revolves around a profound commitment to harnessing cutting-edge science and technology to help individuals lead more fulfilling and intelligent lives.
Dr. Lowemann’s influence extends to the educational platform BetterSmarter.me, where he shares his insights, findings, and personal development strategies with a broader audience. His ongoing mission is shaping the way we perceive and leverage the vast capacities of the human mind, offering invaluable contributions to society’s overall success and collective well-being.